Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - SYNAGEVA BIOPHARMA CORP | d856934dex312.htm |
| EX-31.1 - EX-31.1 - SYNAGEVA BIOPHARMA CORP | d856934dex311.htm |
| EX-21.1 - EX-21.1 - SYNAGEVA BIOPHARMA CORP | d856934dex211.htm |
| EX-32.1 - EX-32.1 - SYNAGEVA BIOPHARMA CORP | d856934dex321.htm |
| EX-10.19 - EX-10.19 - SYNAGEVA BIOPHARMA CORP | d856934dex1019.htm |
| EXCEL - IDEA: XBRL DOCUMENT - SYNAGEVA BIOPHARMA CORP | Financial_Report.xls |
| 10-K - FORM 10-K - SYNAGEVA BIOPHARMA CORP | d856934d10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-197046, 333-189608, 333-185351, 333-185349, 333-177827, 333-172812 and 333-147430) and Form S-3 (No. 333-185856) of Synageva BioPharma Corp. of our report dated February 26, 2015 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
February 26, 2015